Categories: Health

Floe Health Launches to Power Intelligence at Every Patient Touchpoint

 | Source: Floe Health

San Francisco, CA, July 28, 2025 (GLOBE NEWSWIRE) — Floe Health, a new Healthcare AI company focused on solving the hidden operational gaps in healthcare, today announced the official launch of its platform built to manage high-friction patient workflows across the care journey — from intake and calls to follow-ups and referrals.

Backed by clinical leaders and already live in enterprise settings, Floe is the first product to help health systems act intelligently across patient interactions between visits — reducing leakage, improving throughput, and increasing retention without adding headcount.

“Most of healthcare’s breakdowns happen in the space between visits,” said Anirudh, Co-founder of Floe Health. “Missed calls, delayed intake, unclosed referrals. These problems cost health systems billions and burn out staff. We built Floe to act on those gaps, intelligently and automatically.”

Unlike point solutions focused on one task, Floe connects the full chain of patient touchpoints — tracing where patients stall, and triggering the right actions across voice, web, and form-based workflows. It integrates directly with existing EHR and telephony systems and can be deployed in days.

Floe is currently expanding availability and offering a limited number of pilots to health systems, community clinics, and multisite groups across the U.S. and abroad.

To learn more or request a pilot, visit https://floe.health

About Floe Health

Floe Health is the intelligence behind every patient touchpoint. We build enterprise-grade AI that automates high-friction workflows across calls, intake, follow-ups, and referrals — helping clinicians reduce friction, administrators move faster, and operations leaders close the loop. Backed by global clinical leaders, Floe is trusted by forward-thinking health systems to improve access, retention, and coordination without adding tools or staff. 

Press inquiries

Floe Health
https://floe.health/
Floe Health
contact@floe.health

GlobeNews Wire

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

4 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

4 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

11 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

11 hours ago